- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01380860
Primary Prevention of Peristomial Hernias Via Parietal Prostheses (GRECCAR 07)
November 24, 2025 updated by: Centre Hospitalier Universitaire de Nīmes
Primary Prevention of Peristomial Hernias Via Parietal Prostheses: a Randomized, Multicentric Study
The purpose of this study is to compare rates of hernia formation between colostomies created with no hernia preventing mesh versus colostomies created with a particular mesh.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Previous studies indicate that implanting mesh for peristomal hernia repair may efficiently prevent hernia relapse.
However, mesh provides a good infection site, which is not a desirable characteristic for a material adjacent to a colostomy "port".
Our goal is to implement a high-quality, randomized trial to demonstrate whether or not systematic mesh implantation upon primary hernia creation is an effective means of avoiding this common and troublesome complication.
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Besançon, France, 25030
- CHRU De Besancon
-
Bordeaux, France, 33075
- CHU de Bordeaux
-
Clermont-Ferrand, France, 63058
- CHRU de Clermont Ferrand
-
Clichy, France, 92110
- APHP - Hôpital Beaujon
-
Grenoble, France, 38043
- Hôpital Albert Michallon, CHU de Grenoble
-
Le Kremlin-Bicêtre, France, 94275
- APHP - Centre Hospitalier Universitaire de Bicêtre
-
Lille, France, 59037
- CHRU de Lille - Hopital Claude Huriez
-
Lille, France, 59020
- Centre de Lutte contre le Cancer - Centre Oscar Lambret
-
Lyon, France, 69317
- CHU de Lyon
-
Marseille, France, 13385
- APHM - Hôpital La Timone Adultes
-
Marseille, France, 13009
- Centre Régional de Lutte Contre le Cancer - Institut Paoli-Calmettes
-
Montpellier, France, 34298
- Centre Régional de Lutte Contre le Cancer Val d'Aurelle - Paul Lamarque
-
Nantes, France, 44093
- CHU de Nantes
-
Nîmes, France, 30029
- Centre Hospitalier Universitaire de Nîmes
-
Paris, France, 75010
- APHP - Hôpital Lariboisière
-
Paris, France, 75651
- APHP - Groupe Hospitalier Pitié-Salpetrière
-
Paris, France, 75571
- APHP - Hôpital Saint-Antoine
-
Rennes, France, 35033
- Hôpital Pontchailou
-
Rouen, France, 76038
- CHU de Rouen
-
Strasbourg, France, 67065
- Centre Régional de Lutte contre le Cancer Centre Paul Strauss
-
Toulouse, France
- CHU de Toulouse
-
Vichy, France, 03207
- CH de Vichy - Jacques Larin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- The patient has given informed consent
- The patient must be affiliated with a health insurance programme
- The patient must be available for 24 months of follow-up
- The patient requires a colostomy (primo-event, ie first colostomies only)
Exclusion Criteria:
- The patient is currently participating in another interventional study
- The patient is in an exclusion period determined by a previous study
- The patient is under guardianship
- The patient refuses to sign the consent
- It is impossible to communicate information to the patient (does not read French)
- The patient is pregnant
- The patient is breastfeeding
- There is a contra-indication for any treatment used in this study
- The subject has already had a colostomy
- The subject has peritonitis
- The subject needs a colostomy for infectious reasons
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mesh
The patients allocated to this arm of the study will have mesh (Covidien France: mono filament polyester bidimensional knit) implanted in association with their colostomy.
|
Colostomy with mesh implantation
|
|
Active Comparator: No mesh
The patients allocated to this arm of the protocol will not receive mesh implantation with their colostomy.
|
Colostomy with no mesh implantation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence/absence of a peristomal hernia
Time Frame: 24 months
|
The occurrence of peristomal hernias is determined in both groups every three months up until 24 months.
The presence of absence of a hernia is detected by clinical exam, and at 24 months by an additional radiology exam.
The primary outcome concerns rates at 24 months, primo-events only.
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence/absence of peristomal hernia
Time Frame: 12 months
|
The presence of absence of a hernia is detected by clinical exam.
|
12 months
|
|
Days of hospitalisation
Time Frame: 1 month
|
The number of days spent in the hospital after the surgical intervention.
|
1 month
|
|
Operating time (minutes)
Time Frame: Day 1
|
Day 1
|
|
|
Estimation of blood loss during the operation (ml)
Time Frame: Day 1
|
Day 1
|
|
|
Was stomal repair necessary for the patient? yes/no
Time Frame: 24 months
|
24 months
|
|
|
Was relocation of the colostomy required? yes/no
Time Frame: 24 months
|
24 months
|
|
|
Presence/absence of complications
Time Frame: 24 months
|
Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration
|
24 months
|
|
Patient difficulty for fitting his/her colostomy with the appropriate sac.
Time Frame: 24 months
|
A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device.
0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.
|
24 months
|
|
Pain around the colostomy
Time Frame: 24 months
|
A visual analog scale is used to assess the patient's perception of pain around the stomy site.
|
24 months
|
|
Abdominal pain
Time Frame: 24 months
|
A visual analog scale is used to assess the patient's perception of abdominal pain.
|
24 months
|
|
Pain medication consumption
Time Frame: 24 months
|
24 months
|
|
|
Number of colostomy leaks per day
Time Frame: 24 months
|
24 months
|
|
|
Number of colostomy sac changes per day
Time Frame: 24 months
|
24 months
|
|
|
Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no
Time Frame: 24 months
|
24 months
|
|
|
Questionnaire Stoma-QOL
Time Frame: 24 months
|
Validated assessment of quality of life.
|
24 months
|
|
Exposition of the prothesis (mesh): yes/no
Time Frame: 24 months
|
24 months
|
|
|
Questionnaire Stoma-QOL
Time Frame: 12 months
|
Validated assessment of quality of life.
|
12 months
|
|
Questionnaire Stoma-QOL
Time Frame: 1 month
|
Validated assessment of quality of life.
|
1 month
|
|
Presence/absence of peri-operative complications
Time Frame: Day 1
|
Day 1
|
|
|
Pain around the colostomy
Time Frame: Day 1
|
A visual analog scale is used to assess the patient's perception of pain around the stomy site.
|
Day 1
|
|
Pain around the colostomy
Time Frame: 1 month
|
A visual analog scale is used to assess the patient's perception of pain around the stomy site.
|
1 month
|
|
Pain around the colostomy
Time Frame: 3 months
|
A visual analog scale is used to assess the patient's perception of pain around the stomy site.
|
3 months
|
|
Pain around the colostomy
Time Frame: 6 months
|
A visual analog scale is used to assess the patient's perception of pain around the stomy site.
|
6 months
|
|
Pain around the colostomy
Time Frame: 9 months
|
A visual analog scale is used to assess the patient's perception of pain around the stomy site.
|
9 months
|
|
Pain around the colostomy
Time Frame: 12 months
|
A visual analog scale is used to assess the patient's perception of pain around the stomy site.
|
12 months
|
|
Pain around the colostomy
Time Frame: 15 months
|
A visual analog scale is used to assess the patient's perception of pain around the stomy site.
|
15 months
|
|
Pain around the colostomy
Time Frame: 18 months
|
A visual analog scale is used to assess the patient's perception of pain around the stomy site.
|
18 months
|
|
Pain around the colostomy
Time Frame: 21 months
|
A visual analog scale is used to assess the patient's perception of pain around the stomy site.
|
21 months
|
|
Abdominal pain
Time Frame: Day 1
|
A visual analog scale is used to assess the patient's perception of abdominal pain.
|
Day 1
|
|
Abdominal pain
Time Frame: 1 month
|
A visual analog scale is used to assess the patient's perception of abdominal pain.
|
1 month
|
|
Abdominal pain
Time Frame: 3 months
|
A visual analog scale is used to assess the patient's perception of abdominal pain.
|
3 months
|
|
Abdominal pain
Time Frame: 6 months
|
A visual analog scale is used to assess the patient's perception of abdominal pain.
|
6 months
|
|
Abdominal pain
Time Frame: 9 months
|
A visual analog scale is used to assess the patient's perception of abdominal pain.
|
9 months
|
|
Abdominal pain
Time Frame: 12 months
|
A visual analog scale is used to assess the patient's perception of abdominal pain.
|
12 months
|
|
Abdominal pain
Time Frame: 15 months
|
A visual analog scale is used to assess the patient's perception of abdominal pain.
|
15 months
|
|
Abdominal pain
Time Frame: 18 months
|
A visual analog scale is used to assess the patient's perception of abdominal pain.
|
18 months
|
|
Abdominal pain
Time Frame: 21 months
|
A visual analog scale is used to assess the patient's perception of abdominal pain.
|
21 months
|
|
Presence/absence of peristomal hernia
Time Frame: 1 month
|
The presence of absence of a hernia is detected by clinical exam.
|
1 month
|
|
Presence/absence of peristomal hernia
Time Frame: 3 months
|
The presence of absence of a hernia is detected by clinical exam.
|
3 months
|
|
Presence/absence of peristomal hernia
Time Frame: 6 months
|
The presence of absence of a hernia is detected by clinical exam.
|
6 months
|
|
Presence/absence of peristomal hernia
Time Frame: 9 months
|
The presence of absence of a hernia is detected by clinical exam.
|
9 months
|
|
Presence/absence of peristomal hernia
Time Frame: 15 months
|
The presence of absence of a hernia is detected by clinical exam.
|
15 months
|
|
Presence/absence of peristomal hernia
Time Frame: 18 months
|
The presence of absence of a hernia is detected by clinical exam.
|
18 months
|
|
Presence/absence of peristomal hernia
Time Frame: 21 months
|
The presence of absence of a hernia is detected by clinical exam.
|
21 months
|
|
Presence/absence of complications
Time Frame: 1 month
|
Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration
|
1 month
|
|
Presence/absence of complications
Time Frame: 3 months
|
Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration
|
3 months
|
|
Presence/absence of complications
Time Frame: 6 months
|
Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration
|
6 months
|
|
Presence/absence of complications
Time Frame: 9 months
|
Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration
|
9 months
|
|
Presence/absence of complications
Time Frame: 12 months
|
Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration
|
12 months
|
|
Presence/absence of complications
Time Frame: 15 months
|
Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration
|
15 months
|
|
Presence/absence of complications
Time Frame: 18 months
|
Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration
|
18 months
|
|
Presence/absence of complications
Time Frame: 21 months
|
Complications include: retraction, stenosis, prolapse, disunion, necrosis, abcess, infections, occlusion, strangulation, perforation, eczema, dermatitis, erythema, ulceration
|
21 months
|
|
Patient difficulty for fitting his/her colostomy with the appropriate sac.
Time Frame: Day 1
|
A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device.
0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.
|
Day 1
|
|
Patient difficulty for fitting his/her colostomy with the appropriate sac.
Time Frame: 1 month
|
A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device.
0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.
|
1 month
|
|
Patient difficulty for fitting his/her colostomy with the appropriate sac.
Time Frame: 3 months
|
A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device.
0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.
|
3 months
|
|
Patient difficulty for fitting his/her colostomy with the appropriate sac.
Time Frame: 6 months
|
A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device.
0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.
|
6 months
|
|
Patient difficulty for fitting his/her colostomy with the appropriate sac.
Time Frame: 9 months
|
A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device.
0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.
|
9 months
|
|
Patient difficulty for fitting his/her colostomy with the appropriate sac.
Time Frame: 12 months
|
A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device.
0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.
|
12 months
|
|
Patient difficulty for fitting his/her colostomy with the appropriate sac.
Time Frame: 15 months
|
A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device.
0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.
|
15 months
|
|
Patient difficulty for fitting his/her colostomy with the appropriate sac.
Time Frame: 18 months
|
A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device.
0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.
|
18 months
|
|
Patient difficulty for fitting his/her colostomy with the appropriate sac.
Time Frame: 21 months
|
A visual analog scale is used to determine how difficult it is for a patient to fit his/her colostomy with an appropriate device.
0: perfect adhesion; 10: the device does not adjust to the shape of my skin, and I have permanent leakage.
|
21 months
|
|
Pain medication consumption
Time Frame: Day 1
|
Day 1
|
|
|
Pain medication consumption
Time Frame: 1 month
|
1 month
|
|
|
Pain medication consumption
Time Frame: 3 months
|
3 months
|
|
|
Pain medication consumption
Time Frame: 6 months
|
6 months
|
|
|
Pain medication consumption
Time Frame: 9 months
|
9 months
|
|
|
Pain medication consumption
Time Frame: 12 months
|
12 months
|
|
|
Pain medication consumption
Time Frame: 15 months
|
15 months
|
|
|
Pain medication consumption
Time Frame: 18 months
|
18 months
|
|
|
Pain medication consumption
Time Frame: 21 months
|
21 months
|
|
|
Number of colostomy leaks per day
Time Frame: Day 1
|
Day 1
|
|
|
Number of colostomy leaks per day
Time Frame: 1 month
|
1 month
|
|
|
Number of colostomy leaks per day
Time Frame: 3 months
|
3 months
|
|
|
Number of colostomy leaks per day
Time Frame: 6 months
|
6 months
|
|
|
Number of colostomy leaks per day
Time Frame: 9 months
|
9 months
|
|
|
Number of colostomy leaks per day
Time Frame: 12 months
|
12 months
|
|
|
Number of colostomy leaks per day
Time Frame: 18 months
|
18 months
|
|
|
Number of colostomy leaks per day
Time Frame: 15 months
|
15 months
|
|
|
Number of colostomy leaks per day
Time Frame: 21 months
|
21 months
|
|
|
Number of colostomy sac changes per day
Time Frame: Day 1
|
Day 1
|
|
|
Number of colostomy sac changes per day
Time Frame: 1 month
|
1 month
|
|
|
Number of colostomy sac changes per day
Time Frame: 3 months
|
3 months
|
|
|
Number of colostomy sac changes per day
Time Frame: 6 months
|
6 months
|
|
|
Number of colostomy sac changes per day
Time Frame: 9 months
|
9 months
|
|
|
Number of colostomy sac changes per day
Time Frame: 12 months
|
12 months
|
|
|
Number of colostomy sac changes per day
Time Frame: 15 months
|
15 months
|
|
|
Number of colostomy sac changes per day
Time Frame: 18 months
|
18 months
|
|
|
Number of colostomy sac changes per day
Time Frame: 21 months
|
21 months
|
|
|
Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no
Time Frame: Day 1
|
Day 1
|
|
|
Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no
Time Frame: 1 month
|
1 month
|
|
|
Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no
Time Frame: 3 months
|
3 months
|
|
|
Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no
Time Frame: 6 months
|
6 months
|
|
|
Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no
Time Frame: 9 months
|
9 months
|
|
|
Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no
Time Frame: 12 months
|
12 months
|
|
|
Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no
Time Frame: 15 months
|
15 months
|
|
|
Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no
Time Frame: 18 months
|
18 months
|
|
|
Does the patient consider fitting a sac to his/her colostomy to be a difficult task? yes/no
Time Frame: 21 months
|
21 months
|
|
|
Exposition of the prothesis (mesh): yes/no
Time Frame: 1 month
|
1 month
|
|
|
Exposition of the prothesis (mesh): yes/no
Time Frame: 3 months
|
3 months
|
|
|
Exposition of the prothesis (mesh): yes/no
Time Frame: 6 months
|
6 months
|
|
|
Exposition of the prothesis (mesh): yes/no
Time Frame: 9 months
|
9 months
|
|
|
Exposition of the prothesis (mesh): yes/no
Time Frame: 12 months
|
12 months
|
|
|
Exposition of the prothesis (mesh): yes/no
Time Frame: 15 months
|
15 months
|
|
|
Exposition of the prothesis (mesh): yes/no
Time Frame: 18 months
|
18 months
|
|
|
Exposition of the prothesis (mesh): yes/no
Time Frame: 21 months
|
21 months
|
|
|
Presence/absence of a complication potentially linked to the presence of a mesh?
Time Frame: 1 month
|
1 month
|
|
|
Presence/absence of a complication potentially linked to the presence of a mesh?
Time Frame: 3 months
|
3 months
|
|
|
Presence/absence of a complication potentially linked to the presence of a mesh?
Time Frame: 6 months
|
6 months
|
|
|
Presence/absence of a complication potentially linked to the presence of a mesh?
Time Frame: 9 months
|
9 months
|
|
|
Presence/absence of a complication potentially linked to the presence of a mesh?
Time Frame: 12 months
|
12 months
|
|
|
Presence/absence of a complication potentially linked to the presence of a mesh?
Time Frame: 15 months
|
15 months
|
|
|
Presence/absence of a complication potentially linked to the presence of a mesh?
Time Frame: 18 months
|
18 months
|
|
|
Presence/absence of a complication potentially linked to the presence of a mesh?
Time Frame: 21 months
|
21 months
|
|
|
Presence/absence of a complication potentially linked to the presence of a mesh?
Time Frame: 24 months
|
24 months
|
|
|
Ablation of the mesh: yes/no
Time Frame: 1 month
|
1 month
|
|
|
Ablation of the mesh: yes/no
Time Frame: 3 months
|
3 months
|
|
|
Ablation of the mesh: yes/no
Time Frame: 6 months
|
6 months
|
|
|
Ablation of the mesh: yes/no
Time Frame: 9 months
|
9 months
|
|
|
Ablation of the mesh: yes/no
Time Frame: 12 months
|
12 months
|
|
|
Ablation of the mesh: yes/no
Time Frame: 15 months
|
15 months
|
|
|
Ablation of the mesh: yes/no
Time Frame: 18 months
|
18 months
|
|
|
Ablation of the mesh: yes/no
Time Frame: 21 months
|
21 months
|
|
|
Ablation of the mesh: yes/no
Time Frame: 24 months
|
24 months
|
|
|
Evaluation of colostomy healing by the clinician
Time Frame: Day 1
|
The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.
|
Day 1
|
|
Evaluation of colostomy healing by the clinician
Time Frame: 1 month
|
The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.
|
1 month
|
|
Evaluation of colostomy healing by the clinician
Time Frame: 3 months
|
The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.
|
3 months
|
|
Evaluation of colostomy healing by the clinician
Time Frame: 6 months
|
The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.
|
6 months
|
|
Evaluation of colostomy healing by the clinician
Time Frame: 9 months
|
The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.
|
9 months
|
|
Evaluation of colostomy healing by the clinician
Time Frame: 12 months
|
The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.
|
12 months
|
|
Evaluation of colostomy healing by the clinician
Time Frame: 15 months
|
The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.
|
15 months
|
|
Evaluation of colostomy healing by the clinician
Time Frame: 18 months
|
The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.
|
18 months
|
|
Evaluation of colostomy healing by the clinician
Time Frame: 21 months
|
The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.
|
21 months
|
|
Evaluation of colostomy healing by the clinician
Time Frame: 24 months
|
The evaluating clinician (blind to the procedure) will evaluate the healing progress of the colostomy using a visual analog scale.
|
24 months
|
|
Duration of postoperative fever (hours)
Time Frame: 10 days
|
10 days
|
|
|
Presence/absence of postoperative fever > 37.2°C
Time Frame: Day 1
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Michel Prudhomme, MD, PhD, Centre Hospitalier Universitaire de Nîmes
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Prudhomme M, Alline M, Chauvat J, Fabbro-Perray P, Ripoche J, Bertrand MM; French Research Group of Rectal Cancer Surgery (GRECCAR). Primary prevention of peristomial hernias via parietal prostheses: A randomized, multicentric study (GRECCAR 7 trial). Dig Liver Dis. 2016 Jul;48(7):812-6. doi: 10.1016/j.dld.2016.03.020. Epub 2016 Apr 5.
- Prudhomme M, Rullier E, Lakkis Z, Cotte E, Panis Y, Meunier B, Rouanet P, Tuech JJ, Jafari M, Portier G, Dubois A, Sielezneff I, Parc Y, Faucheron JL, Meurette G, Lelong B, Piessen G, Karoui M, Fabbro-Peray P, Demattei C, Bertrand MM; GRECCAR research group. End Colostomy With or Without Mesh to Prevent a Parastomal Hernia (GRECCAR 7): A Prospective, Randomized, Double Blinded, Multicentre Trial. Ann Surg. 2021 Dec 1;274(6):928-934. doi: 10.1097/SLA.0000000000004371.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2012
Primary Completion (Actual)
December 31, 2018
Study Completion (Actual)
December 31, 2018
Study Registration Dates
First Submitted
June 22, 2011
First Submitted That Met QC Criteria
June 23, 2011
First Posted (Estimated)
June 27, 2011
Study Record Updates
Last Update Posted (Estimated)
December 1, 2025
Last Update Submitted That Met QC Criteria
November 24, 2025
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PHRC-N/2011/MP-01
- 2011-A01572-39 (Other Identifier: ANSM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.